0001209191-15-083139.txt : 20151203 0001209191-15-083139.hdr.sgml : 20151203 20151203143252 ACCESSION NUMBER: 0001209191-15-083139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151201 FILED AS OF DATE: 20151203 DATE AS OF CHANGE: 20151203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xencor Inc CENTRAL INDEX KEY: 0001326732 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201622502 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 WEST LEMON AVE CITY: MONROVIA STATE: CA ZIP: 91016 BUSINESS PHONE: 626-305-5900 MAIL ADDRESS: STREET 1: 111 WEST LEMON AVE CITY: MONROVIA STATE: CA ZIP: 91016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baracchini Edgardo Jr CENTRAL INDEX KEY: 0001291972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36182 FILM NUMBER: 151267072 MAIL ADDRESS: STREET 1: C/O METABASIS THERAPEUTICS STREET 2: 9390 TOWNE CENTRE DRIVE, BLDG. 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-01 0 0001326732 Xencor Inc XNCR 0001291972 Baracchini Edgardo Jr C/O XENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016 0 1 0 0 Chief Business Officer Common Stock 2015-12-01 4 M 0 1250 0.59 A 1250 D Common Stock 2015-12-01 4 S 0 1250 15.9268 D 0 D Stock Option (right to buy) 0.59 2015-12-01 4 M 0 1250 0.00 D 2020-01-17 Common Stock 1250 171921 D Reported transaction occured pursuant to a Rule 10b5-1 Plan adopted March 13, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.81 to $16.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. 25% of the shares subject to the option vested on the one year anniversary of January 12, 2010 (the "Vesting Commencement Date"), and 1/48th of the shares vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date. /s/ Lloyd Rowland, Attorney-in-Fact 2015-12-02